-31.35 (-1.84%) Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release relating to the Earnings Call for financial results for the first quarter ending June 30, 2024, which will be releasing after sending this letter.
The above information is a part of company’s filings submitted to BSE.